5-Minute Focus: What the New EULAR-ACR Classification Criteria Mean for Antiphospholipid Syndrome

Today on The Wellness Pharmacist with Dr. Kat, we’re taking a closer look at an important study published in The Lancet Rheumatology in March 2025.

Key Takeaways from the Study

🔹Improved Precision for Pregnant Individuals with APS

🔹 Not a Diagnostic Tool for Routine Clinical Use

🔹 Advancing Research & Treatment

Listener Question:

📞 “Hi Dr. Kat, I’ve had multiple miscarriages, but my doctor never mentioned APS. Should I ask to be tested?”